PharVision Advisers’s Petrobras PBR Stock Holding History

PharVision Advisers’s Portfolio PBR Stock Details PBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-38,680	Closed	-$458K	–	499
2025 Q4	$458K	Buy	+38,680	New	+$472K	0.23%	63

Other funds holding PBR

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

AIM

ARGA Investment Management Stamford, Connecticut $3.05B AUM 47.96% 1-Year Est. Return

PharVision Advisers's PBR Position: Q1 2026 in Review

PharVision Advisers sold out of Petrobras (PBR) in Q1 2026, closing a stake of 38,680 shares — an estimated $458K sold.

PharVision Advisers first reported a position in PBR in Q4 2025 and held it in 1 quarter. The position peaked at $458K in Q4 2025. 545 funds tracked by Wall St. Rank hold PBR as of Q1 2026.

PharVision Advisers reported no remaining Petrobras position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 38,680 Petrobras shares in Q1 2026, an estimated $458K.
PharVision Advisers first reported a position in Petrobras in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Petrobras position peaked at $458K in Q4 2025.
545 funds tracked by Wall St. Rank held Petrobras as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.